Effect of the Apolipoprotein E ε4 Allele on the Efficacy and Tolerability of Galantamine in the Treatment of Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|21|1|33-39

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.21, Iss.1, 2005-12, pp. : 33-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apolipoprotein E ε4 Allele Differentiates the Clinical Response to Donepezil in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 20, Iss. 4, 2005-09 ,pp. : 254-261

Karger

Access to resources Recommend Favorite

Depression in Alzheimer’s Disease Might Be Associated with Apolipoprotein E ε4 Allele Frequency in Women but Not in Men

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 2, 2002-07 ,pp. : 59-63

Karger

Access to resources Recommend Favorite

Apolipoprotein E ε4 Allele Is Unrelated to Cognitive or Functional Decline in Alzheimer’s Disease: Retrospective and Prospective Analysis

By  

Dementia and Geriatric Cognitive Disorders, Vol. 22, Iss. 1, 2006-06 ,pp. : 73-82

Karger

Access to resources Recommend Favorite

Apolipoprotein E ε4 Allele Frequency and Age at Onset of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 1, 2006-11 ,pp. : 60-66

Karger

Access to resources Recommend Favorite

Apolipoprotein E ε4 Allele Is a Risk Factor for Alzheimer’s Disease: The Central Region of Portugal (Coimbra) as a Case Study

By  

European Neurology, Vol. 42, Iss. 3, 1999-10 ,pp. : 183-184

Karger

Access to resources Recommend Favorite